Published: 2018-12-08

Articles

BUILDING A STRUCTURED MONITORING AND EVALUATING SYSTEM OF POSTMARKETING DRUG USE IN SHANGHAI

Wenmin Du, Mitchell Levine, Longxing Wang, Chengdong Yi, Hongmin Wang, Xiaoyu Wang, Hongjuan Xie Xie, Jianglong Xu, Huilin Jin, Tongchun Wang, Gang Huang, Ye Wu
Abstract 374 | PDF Downloads 190
PDF

COUNSELING REGARDING PREGNANCY- RELATED DRUG EXPOSURES BY FAMILY PHYSICIANS IN ONTARIO

Jodi Goodwin, Scott Rieder, Michael J Rieder, Doreen Matsui
Abstract 261 | PDF Downloads 138
PDF

45 YEARS LATER… WHERE DO WE STAND?

Mercédes Benegbi
Abstract 245 | PDF Downloads 123
PDF

PAEDIATRIC ADVERSE DRUG REACTION REPORTING: UNDERSTANDING AND FUTURE DIRECTIONS

Bruce C Carleton, M Anne Smith, Michaela N Gelin, Susan C Heathcote
Abstract 540 | PDF Downloads 293
PDF

ESTABLISHING A NEW BENCHMARK FOR DRUG EVALUATION DURING PREGNANCY

Gideon Koren
Abstract 843 | PDF Downloads 102
PDF

DRUGS IN PREGNANCY: ACKNOWLEDGING CHALLENGES - FINDING SOLUTIONS

Gideon Koren, Stuart MacLeod, Donald Davis
Abstract 1184 | PDF Downloads 167
PDF

DRUGS USED IN PREGNANCY: THE REGULATORY PROCESS

Anne Tomalin
Abstract 259 | PDF Downloads 393
PDF

THE WAY WOMEN PERCEIVE TERATOGENIC RISK

Gideon Koren
Abstract 1249 | PDF Downloads 334
PDF

INACTIVE PHARMACEUTICAL INGREDIENTS: IMPLICATIONS FOR PREGNANCY

Yaron Finkelstein, Massoud Rezvani, Facundo Garcia-Bournissen, Laila Nurmohamed, Gideon Koren
Abstract 1964 | PDF Downloads 779
PDF

CHALLENGES IN DRUG USE NEAR TERM AND DURING DELIVERY

Dan Farine
Abstract 237 | PDF Downloads 129
PDF

COLLECTION AND ANALYSIS OF DRUG SAFETY DATA IN PREGNANCY

Myla Moretti
Abstract 220 | PDF Downloads 113
PDF

COLLECTION AND ANALYSIS OF DRUG SAFETY DATA IN PREGNANCY

Myla Moretti
Abstract 225 | PDF Downloads 99
PDF

CRITICAL APPRAISAL ROUNDS: A NEW TRAINING MODEL FOR CLINICAL PHARMACOLOGISTS

Gideon Koren, Irena Nulman
Abstract 1134 | PDF Downloads 144
PDF

USE OF CELECOXIB IMMEDIATELY POST MARKETING IN CANADA: ACUTE OR CHRONIC PAI N?

Anita L Kozyrskyj, Colette Raymond, Amber Racher Racher
Abstract 297 | PDF Downloads 173
PDF

ESTABLISHING A NEW BENCHMARK FOR DRUG EVALUATION DURING PREGNANCY

Gideon Koren
Abstract 1127 | PDF Downloads 118
PDF